Aghaizu, ND;
Jin, H;
Whiting, PJ;
(2020)
Dysregulated Wnt Signalling in the Alzheimer's Brain.
Brain Sciences
, 10
(12)
p. 902.
10.3390/brainsci10120902.
Preview |
Text
brainsci-10-00902.pdf - Published Version Download (1MB) | Preview |
Abstract
The Wnt signalling system is essential for both the developing and adult central nervous system. It regulates numerous cellular functions ranging from neurogenesis to blood brain barrier biology. Dysregulated Wnt signalling can thus have significant consequences for normal brain function, which is becoming increasingly clear in Alzheimer’s disease (AD), an age-related neurodegenerative disorder that is the most prevalent form of dementia. AD exhibits a range of pathophysiological manifestations including aberrant amyloid precursor protein processing, tau pathology, synapse loss, neuroinflammation and blood brain barrier breakdown, which have been associated to a greater or lesser degree with abnormal Wnt signalling. Here we provide a comprehensive overview of the role of Wnt signalling in the CNS, and the research that implicates dysregulated Wnt signalling in the ageing brain and in AD pathogenesis. We also discuss the opportunities for therapeutic intervention in AD via modulation of the Wnt signalling pathway, and highlight some of the challenges and the gaps in our current understanding that need to be met to enable that goal.
Type: | Article |
---|---|
Title: | Dysregulated Wnt Signalling in the Alzheimer's Brain |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.3390/brainsci10120902 |
Publisher version: | https://doi.org/10.3390/brainsci10120902 |
Language: | English |
Additional information: | This is an open access article distributed under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
Keywords: | Wnt signalling; Alzheimer’s disease; neurodegeneration; APP processing; tau pathology; synapse degeneration; neuroinflammation; blood brain barrier |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Department of Neuromuscular Diseases |
URI: | https://discovery.ucl.ac.uk/id/eprint/10116327 |
Archive Staff Only
View Item |